239 related articles for article (PubMed ID: 22921523)
1. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
[TBL] [Abstract][Full Text] [Related]
2. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.
Kaushal N; Robson MJ; Rosen A; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2014 Feb; 724():193-203. PubMed ID: 24380829
[TBL] [Abstract][Full Text] [Related]
4. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
Robson MJ; Turner RC; Naser ZJ; McCurdy CR; O'Callaghan JP; Huber JD; Matsumoto RR
Exp Neurol; 2014 Apr; 254():180-9. PubMed ID: 24508558
[TBL] [Abstract][Full Text] [Related]
5. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
Seminerio MJ; Hansen R; Kaushal N; Zhang HT; McCurdy CR; Matsumoto RR
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1033-44. PubMed ID: 22932447
[TBL] [Abstract][Full Text] [Related]
7. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
Seminerio MJ; Kaushal N; Shaikh J; Huber JD; Coop A; Matsumoto RR
Pharmacol Biochem Behav; 2011 Mar; 98(1):12-20. PubMed ID: 21130800
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.
Matsumoto RR; Shaikh J; Wilson LL; Vedam S; Coop A
Eur Neuropsychopharmacol; 2008 Dec; 18(12):871-81. PubMed ID: 18755577
[TBL] [Abstract][Full Text] [Related]
12. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Liu Q; Hazan A; Grinman E; Angulo JA
Brain Res; 2017 Mar; 1659():148-155. PubMed ID: 28130052
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
[TBL] [Abstract][Full Text] [Related]
16. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.
Robson MJ; Turner RC; Naser ZJ; McCurdy CR; Huber JD; Matsumoto RR
Exp Neurol; 2013 Sep; 247():134-42. PubMed ID: 23631864
[TBL] [Abstract][Full Text] [Related]
17. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.
Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2012 Sep; 691(1-3):103-9. PubMed ID: 22820108
[TBL] [Abstract][Full Text] [Related]
18. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
[TBL] [Abstract][Full Text] [Related]
19. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
Friend DM; Keefe KA
Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
[TBL] [Abstract][Full Text] [Related]
20. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
